Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon-like Peptide-1 Metabolism in the Setting of Acute Neprilysin Inhibition

NCT03508739 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03508739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon-like Peptide-1 Metabolism in the Setting of Acute Neprilysin Inhibition
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Withdrawn
Start date
June 1, 2018
Completion date
June 30, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, elevated blood pressure, hypertension, pre-diabetic